Publications by authors named "David Zahrieh"

50Publications

Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812).

J Geriatr Oncol 2020 Sep 16. Epub 2020 Sep 16.

Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, United States of America; Mayo Clinic, Rochester, MN, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2020.09.005DOI Listing
September 2020

Sample size planning in the design and analysis of cluster randomized trials using the symbolic two-step method.

Contemp Clin Trials Commun 2020 Sep 8;19:100609. Epub 2020 Jul 8.

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.conctc.2020.100609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378578PMC
September 2020

Quantifying geographic regions of excess stillbirth risk in the presence of spatial and spatio-temporal heterogeneity.

Spat Spatiotemporal Epidemiol 2019 06 9;29:97-109. Epub 2019 Apr 9.

Department of Epidemiology, The University of Iowa, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.sste.2019.01.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156247PMC
June 2019

Rose geranium in sesame oil nasal spray: a treatment for nasal vestibulitis?

BMJ Support Palliat Care 2020 Dec 26;10(4):411-413. Epub 2018 Sep 26.

Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://spcare.bmj.com/lookup/doi/10.1136/bmjspcare-2018-0015
Publisher Site
http://dx.doi.org/10.1136/bmjspcare-2018-001569DOI Listing
December 2020

Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment?

Support Care Cancer 2018 Nov 24;26(11):3909-3914. Epub 2018 May 24.

Department of Medical Oncology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4261-7DOI Listing
November 2018

Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-year follow-up.

Blood Cells Mol Dis 2014 Jun-Aug;53(1-2):56-60. Epub 2014 Feb 25.

Gaucher Clinic, Shaare Zedek Medical Center, The Hebrew University-Hadassah School of Medicine, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2014.02.006DOI Listing
January 2015

Down-regulation of CD9 expression and its correlation to tumor progression in B lymphomas.

Am J Pathol 2010 Jul 21;177(1):377-86. Epub 2010 Jun 21.

Laboratory of Cellular Immunology, 1514 Jefferson Highway, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2010.100048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893680PMC
July 2010

CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D.

Breast Cancer Res Treat 2010 Aug 13;123(1):163-9. Epub 2010 May 13.

Danish Breast Cancer Cooperative Group, DBCG Secretariat, Rigshospitalet, Bldg 2501 9, Blegdamsvej, 2100 Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0931-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721366PMC
August 2010

E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction.

Proc Natl Acad Sci U S A 2009 Apr 30;106(15):6250-5. Epub 2009 Mar 30.

Department of Medical Oncology, The Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.0901166106
Publisher Site
http://dx.doi.org/10.1073/pnas.0901166106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669383PMC
April 2009

A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data.

Stat Med 2009 Apr;28(8):1255-68

Department of Decision Sciences, Bocconi University, Via Röntgen 1, Milan 20136, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.3524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843827PMC
April 2009

High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss.

Genes Chromosomes Cancer 2008 Jul;47(7):591-603

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20561DOI Listing
July 2008

Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.

Biol Blood Marrow Transplant 2008 Feb;14(2):197-207

Division of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.10.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259445PMC
February 2008

Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial.

Cancer 2007 May;109(9):1863-9

Department of Medical Oncology, Center for Sarcoma and Bone Oncology and Ludwig Center for Cancer Research, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22609DOI Listing
May 2007

Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide.

Blood 2006 Dec 10;108(12):3865-70. Epub 2006 Aug 10.

Institute of Cancer, Barts and The London School of Medicine, Charterhouse Square, London EC1M 6BQ, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-014415DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895467PMC
December 2006

Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.

J Clin Oncol 2006 May;24(15):2325-31

Department of Surgery,Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.3439DOI Listing
May 2006

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

J Clin Invest 2005 Jul 16;115(7):1797-805. Epub 2005 Jun 16.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI24176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1150284PMC
July 2005

Ferroportin1 is required for normal iron cycling in zebrafish.

J Clin Invest 2005 Jun 5;115(6):1532-41. Epub 2005 May 5.

Division of Hematology/Oncology, Children's Hospital, Karp Research Laboratories, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI23780DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1089797PMC
June 2005

Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.

Br J Haematol 2005 May;129(4):499-510

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2005.05480.xDOI Listing
May 2005

Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells.

Blood 2004 Dec 25;104(13):4002-9. Epub 2004 May 25.

Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 44 Binney St, Rm D520, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2004-02-04
Publisher Site
http://dx.doi.org/10.1182/blood-2004-02-0494DOI Listing
December 2004

Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy.

Transfusion 2004 Feb;44(2):253-61

Connell O'Reilly Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2004.00666.xDOI Listing
February 2004

Zebrafish sperm cryopreservation with N,N-dimethylacetamide.

Biotechniques 2003 Nov;35(5):956-8, 960, 962 passim

Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2144/03355st03DOI Listing
November 2003

In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.

Clin Cancer Res 2003 Jun;9(6):2166-72

Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
June 2003

Early neutrophil engraftment following autologous BMT provides a functional predictor of long-term hematopoietic reconstitution.

Transfusion 2003 May;43(5):614-21

Connell O'Reilly Cell Manipulation Core Facility and the Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1537-2995.2003.00369.xDOI Listing
May 2003

Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs.

Blood 2002 Oct;100(8):2697-702

Department of Adult Oncology and Department of Biostatistical Science, Dana-Farber Cancer Institute, and the Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-03-0984DOI Listing
October 2002

Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.

Transplantation 2002 Jul;74(1):49-54

Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00007890-200207150-00009DOI Listing
July 2002